Brønshøj, Denmark

Ditte Riber

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 4.0

ph-index = 12

Forward Citations = 357(Granted Patents)


Location History:

  • Frederiksberg, DK (2011 - 2014)
  • Broenshoej, DK (2015 - 2018)
  • Glostrup, DK (2019 - 2022)
  • Brønshøj, DK (2015 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Ditte Riber:

Title: Innovator Spotlight: Ditte Riber - Pioneering Glucagon Analogues for Better Health

Introduction:

In the realm of medical innovation, Danish inventor Ditte Riber stands out as a trailblazer in developing cutting-edge solutions for obesity, diabetes, and metabolic disorders. With a total of 29 patents to his name, Riber has made significant contributions to the field of biotechnology, particularly in the area of acylated glucagon analogues.

Latest Patents:

Riber's latest patents showcase his dedication to revolutionizing the treatment of metabolic disorders. His invention of acylated glucagon analogues offers new materials and methods for addressing obesity, excess weight, diabetes, and related conditions. These novel peptides exhibit enhanced selectivity for the GLP-1 receptor, presenting promising avenues for therapeutic interventions.

Moreover, Riber's advancements in stable glucagon analogues have paved the way for improved treatments for hypoglycemia. By developing formulations that enhance the stability and efficacy of glucagon analogues in liquid form, Riber has opened doors to more convenient and effective medical interventions.

Career Highlights:

Throughout his career, Ditte Riber has been associated with prominent companies at the forefront of biotechnological research. Notably, Riber has collaborated with Zealand Pharma A/S, a leading pharmaceutical company known for its innovative approaches to metabolic therapies. His tenure at Zealand Pharma A/S has been marked by groundbreaking discoveries that have the potential to reshape the landscape of medical care.

Collaborations:

In his professional journey, Ditte Riber has collaborated with accomplished peers in the field of biotechnology. Notable co-workers include Jakob Lind Tolborg and Dieter Wolfgang Hamprecht, individuals who have contributed their expertise to the development of Riber's patented inventions. Together, they form a dynamic team committed to advancing the frontiers of medical science.

Conclusion:

Ditte Riber's outstanding work in the realm of biotechnological innovations underscores his commitment to improving the lives of individuals affected by metabolic disorders. With a robust portfolio of patents and a legacy of collaboration with industry experts, Riber continues to shape the future of healthcare with his pioneering research and inventions.

If you need further information or assistance, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…